AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
19.12.24
/
50%
€14.50
Target price
19.12.25
€34.70
Performance (%)
166.21%
Price
15.12.25
€38.60
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for AnaptysBio Inc has seen massive gains of 166.21%. This prediction currently runs until 19.12.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 2.660% | 2.660% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $66.00 to $36.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat